These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33869220)

  • 1. Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.
    Jiang W; Xu J; Liao Z; Li G; Zhang C; Feng Y
    Front Cell Dev Biol; 2021; 9():655950. PubMed ID: 33869220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma.
    Zhang C; Huang Y; Fang C; Liang Y; Jiang D; Li J; Ma H; Jiang W; Feng Y
    Cancer Biomark; 2023; 36(4):313-326. PubMed ID: 36938730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
    Hu Y; Fan S; Zhu Y; Xie X
    Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Analysis of Cell Cycle-Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma.
    Chen F; Song J; Ye Z; Xu B; Cheng H; Zhang S; Sun X
    Front Oncol; 2021; 11():666826. PubMed ID: 34150632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients.
    Sheng H; Hao Z; Zhu L; Zeng Y; He J
    BMC Cancer; 2022 May; 22(1):572. PubMed ID: 35606717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
    Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
    Front Genet; 2021; 12():720013. PubMed ID: 34777461
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma.
    Zhu J; Mou Y; Ye S; Hu H; Wang R; Yang Q; Hu Y
    Front Cell Dev Biol; 2021; 9():803198. PubMed ID: 34977043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a gene signature associated with iron metabolism in lung adenocarcinoma.
    Qin J; Xu Z; Deng K; Qin F; Wei J; Yuan L; Sun Y; Zheng T; Li S
    Bioengineered; 2021 Dec; 12(1):4556-4568. PubMed ID: 34323652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of chemokine-related genes in acute myeloid leukemia.
    Hou Y; Chen Y; Zhang Y; Li M; Chen J
    PeerJ; 2024; 12():e17862. PubMed ID: 39135956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 5-Gene Signature Improves Lung Adenocarcinoma Prognostic Stratification Based on Differential Expression Invasion Genes of Molecular Subtypes.
    Zheng Z; Deng W; Yang J
    Biomed Res Int; 2020; 2020():8832739. PubMed ID: 33490259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
    Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y
    PeerJ; 2021; 9():e11074. PubMed ID: 33976960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
    Yang X; Wang G; Gu R; Xu X; Zhu G
    PeerJ; 2020; 8():e10418. PubMed ID: 33304656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential prognostic long non‑coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
    Wang X; Ding Y; Da B; Fei Y; Feng G
    Oncol Rep; 2018 Dec; 40(6):3199-3212. PubMed ID: 30272355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.